The DOI matches its Crossref record; 306 of the 306 references it cites were found in a registry or an index.
Methylation matters
Open accessAbstract
DNA methylation is not just for basic scientists any more. There is a growing awareness in the medical field that having the correct pattern of genomic methylation is essential for healthy cells and organs. If methylation patterns are not properly established or maintained, disorders as diverse as mental retardation, immune deficiency, and sporadic or inherited cancers may follow. Through inappropriate silencing of growth regulating genes and simultaneous destabilisation of whole chromosomes, methylation defects help create a chaotic state from which cancer cells evolve. Methylation defects are present in cells before the onset of obvious malignancy and therefore cannot be explained simply as a consequence of a deregulated cancer cell. Researchers are now able to detect with exquisite sensitivity the cells harbouring methylation defects, sometimes months or years before the time when cancer is clinically detectable. Furthermore, aberrant methylation of specific genes has been directly linked with the tumour response to chemotherapy and patient survival. Advances in our ability to observe the methylation status of the entire cancer cell genome have led us to the unmistakable conclusion that methylation abnormalities are far more prevalent than expected. This methylomics approach permits the integration of an ever growing repertoire of methylation defects with the genetic alterations catalogued from tumours over the past two decades. Here we discuss the current knowledge of DNA methylation in normal cells and disease states, and how this relates directly to our current understanding of the mechanisms by which tumours arise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–306 of 306
Epigenetic gene silencing in cancer
Tycko, B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9462 · Cited by 185
Hypermethylation of E-cadherin in leukemia
Melki, J. R., Vincent, P. C., Brown, R. D., & Clark, S. J. (2000) · Blood · doi:10.1182/blood.v95.10.3208 · Cited by 180
Ushijima, T., Morimura, K., Hosoya, Y., Okonogi, H., Tatematsu, M., Sugimura, T., & Nagao, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2284 · Cited by 180
Frequent Hypomethylation in Wilms Tumors of Pericentromeric DNA in Chromosomes 1 and 16
Qu, G.-Z., Grundy, P. E., Narayan, A., & Ehrlich, M. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00143-5 · Cited by 179
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome
Esteller, M., Avizienyte, E., Corn, P. G., Lothe, R. A., Baylin, S. B., Aaltonen, L. A., & Herman, J. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203227 · Cited by 179
Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia
Tsuchiya, T., Tamura, G., Sato, K., Endoh, Y., Sakata, K., Jin, Z., Motoyama, T., Usuba, O., Kimura, W., Nishizuka, S., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203704 · Cited by 176
Jarrard, D. F., Bova, G. S., Ewing, C. M., Pin, S. S., Nguyen, S. H., Baylin, S. B., Cairns, P., Sidransky, D., Herman, J. G., & Isaacs, W. B. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199706)19:2<90::aid-gcc4>3.0.co;2-v · Cited by 175
DNA demethylation and pericentromeric rearrangements of chromosome 1
Ji, W., Hernandez, R., Zhang, X.-Y., Qu, G.-Z., Frady, A., Varela, M., & Ehrlich, M. (1997) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(97)00088-2 · Cited by 174
Kondo, T. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.597 · Cited by 174
Costello, J., Plass, C., Arap, W., Chapman, V. M., Held, W. A., Berger, M. S., Huang, H., & Cavenee, W. K. (1997) · PubMed · Cited by 173
Self-citationMethylation and silencing of the Thrombospondin-1 promoter in human cancer
Li, Q., Ahuja, N., Burger, P. C., & Issa, J.-P. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202663 · Cited by 171
Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon
Woodcock, D. M., Lawler, C. B., Linsenmeyer, M. E., Doherty, J. P., & Warren, W. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7810 · Cited by 168
Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2
Jones, C., Penny, L., Mattina, T., Yu, S., Baker, E., Voullaire, L., Langdon, W. Y., Sutherland, G. R., Richards, R. I., & Tunnacliffe, A. (1995) · Nature · doi:10.1038/376145a0 · Cited by 168
Kim, Y. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2000.tb01863.x · Cited by 168
Inheritance of allelic blueprints for methylation patterns
SILVA, A. (1988) · Cell · doi:10.1016/0092-8674(88)90546-6 · Cited by 168
Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90521-9 · Cited by 167
(2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1999.tb06905.x · Cited by 164
MacLeod, A. R., & Szyf, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8037 · Cited by 159
Toyota, M., Ho, C., Ohe-Toyota, M., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 154
Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
Fujii, H., Biel, M. A., Zhou, W., Weitzman, S. A., Baylin, S. B., & Gabrielson, E. W. (1998) · Oncogene · doi:10.1038/sj.onc.1201976 · Cited by 154
Maraschio, P., Zuffardi, O., Fior, T. D., & Tiepolo, L. (1988) · Journal of Medical Genetics · doi:10.1136/jmg.25.3.173 · Cited by 152
Zeschnigk, M., Schmitz, B., Dittrich, B., Buiting, K., Horsthemke, B., & Doerfler, W. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.3.387 · Cited by 151
Jirtle, R. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4453 · Cited by 149
Graff, J. R., Greenberg, V. L., Herman, J. G., Westra, W. H., Boghaert, E. R., Ain, K. B., Saji, M., Zeiger, M. A., Zimmer, S. G., & Baylin, S. B. (1998) · PubMed · Cited by 148
Qu, G.-Z., Dubeau, L., Narayan, A., Yu, M. C., & Ehrlich, M. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00229-2 · Cited by 148
Tanaka, H., Shimada, Y., Harada, H., Shinoda, M., Hatooka, S., Imamura, M., & Ishizaki, K. (1998) · PubMed · Cited by 146
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
Kantharidis, P., El‐Osta, A., DeSilva, M., Wall, D. M., Hu, X. F., Slater, A. A., Nadalin, G., Parkin, J. D., & Zalcberg, J. R. (1997) · PubMed · Cited by 144
Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Lou, W., Krill, D., Dhir, R., Becich, M. J., Dong, J., Frierson, H. F., Isaacs, W. B., Isaacs, J. T., & Gao, A. C. (1999) · PubMed · Cited by 142
Identification on a human sarcoma of two new genes with tumor-specific expression.
Martelange, V., Smet, C. D., Plaen, E. D., Lurquin, C., & Boon, T. (2000) · Cancer Research · Cited by 139
The 5-Methylcytosine content of highly repeated sequences in human DNA
Gama-Sosa, M. A., Wang, R. Y. ‐., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.10.3087 · Cited by 133
Gene Silencing by Methyl‐CPG‐Binding Proteins
Nan, X., Cross, S. H., & Bird, A. P. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515501.ch2 · Cited by 127
Ehrlich, M., Zhang, X., & Inamdar, N. M. (1990) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(90)90019-8 · Cited by 127
Huang, T. H. ‐., Laux, D. E., Hamlin, B. C., Tran, P., Tran, H., & Lubahn, D. B. (1997) · PubMed · Cited by 125
Bianco‐Miotto, T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.147 · Cited by 124
Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith- Wiedemann syndrome
Joyce, J. A., Lam, W. K., Catchpoole, D. J., Jenks, P., Reik, W., Maher, E. R., & Schofield, P. N. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1543 · Cited by 122
Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma.
Cravo, M. L., Pinto, R., Fidalgo, P., Chaves, P. P., Glória, L., Nobre-Leitao, C. A., & Mira, F. C. (1996) · Gut · doi:10.1136/gut.39.3.434 · Cited by 118
Costello, J., Futscher, B. W., Kroes, R. A., & Pieper, R. O. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6515 · Cited by 117
Self-citationOgawa, O., Becroft, D. M. O., Morison, I. M., Eccles, M. R., Skeen, J., Mauger, D. C., & Reeve, A. E. (1993) · Nature Genetics · doi:10.1038/ng1293-408 · Cited by 116
Baylin, S., Fearon, E., Vogelstein, B., de Bustros, A., Sharkis, S. J., Burke, P., Staal, S., & Nelkin, B. D. (1987) · Blood · doi:10.1182/blood.v70.2.412.412 · Cited by 113
Evidence that Protein Binding Specifies Sites of DNA Demethylation
Hsieh, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.46 · Cited by 110
Differential methylation of human LINE-1 retrotransposons in malignant cells
Alves, G., Tatro, A. V., & Fanning, T. G. (1996) · Gene · doi:10.1016/0378-1119(96)00205-3 · Cited by 108
An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA
Matsuo, K., Silke, J., Georgiev, O., Marti, P., Giovannini, N., & Rungger, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1446 · Cited by 104
Research, U. K. L. U. (1996) · Lung Cancer · doi:10.1016/s0169-5002(97)89504-9 · Cited by 103
Methyl-CpG-binding protein 2 mutations in Rett syndrome
den Veyver, I. B. V., & Zoghbi, H. Y. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00083-6 · Cited by 102
The Host Defence Function of Genomic Methylation Patterns
Bestor, T. H. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515501.ch11 · Cited by 101
Undermethylation of specific LINE-1 sequences in human cells producing a LINE-1 -encoded protein
Thayer, R. E., Singer, M., & Fanning, T. G. (1993) · Gene · doi:10.1016/0378-1119(93)90651-i · Cited by 100
Mammalian Methyltransferases and Methyl-CpG-Binding Domains: Proteins Involved in DNA Methylation
Hendrich, B., & Bird, A. P. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_4 · Cited by 100
Mammalian X-Chromosome Inactivation
Gartler, S. M., & Andina, R. (1976) · Springer eBooks · doi:10.1007/978-1-4757-0659-8_3 · Cited by 98
Reik, W., & Murrell, A. (2000) · Nature · doi:10.1038/35013178 · Cited by 96
Validation studies of SNRPN methylation as a diagnostic test for Prader-Willi syndrome
Kubota, T., Sutcliffe, J. S., Aradhya, S., Gillessen‐Kaesbach, G., Christian, S. L., Horsthemke, B., Beaudet, A. L., & Ledbetter, D. H. (1996) · American Journal of Medical Genetics · Cited by 96
Rice, J. C. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.17.3233 · Cited by 96
Mosaic uniparental disomy in Beckwith-Wiedemann syndrome.
Slatter, R., Elliott, M. M., Welham, K., Carrera, M., Schofield, P. N., Barton, D. E., & Maher, E. R. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.749 · Cited by 95
Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene
Smet, C. D., Courtois-Cox, S., Faraoni, I., Lurquin, C., Szikora, J., Backer, O. D., & Boon, T. (1995) · Immunogenetics · doi:10.1007/bf00176446 · Cited by 94
PAX6 methylation and ectopic expression in human tumor cells
Salem, C. E., Markl, I. D. C., Bender, C. M., Gonzales, F. A., Jones, P. A., & Liang, G. (2000) · International Journal of Cancer · Cited by 89
McConnell, B. B., & Vertino, P. M. (2000) · PubMed · Cited by 88
Nguyen, T. T., Mohrbacher, A., Tsai, Y., Groffen, J., Heisterkamp, N., Nichols, P. W., Yu, M. C., Lübbert, M., & Jones, P. A. (2000) · Blood · doi:10.1182/blood.v95.9.2990.009k08_2990_2992 · Cited by 87
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci
Rush, L. J., Dai, Z., Smiraglia, D. J., Gao, X., Wright, F. A., Frühwald, M., Costello, J. F., Held, W. A., Yu, L., Krahe, R., et al. (2001) · Blood · doi:10.1182/blood.v97.10.3226 · Cited by 86
Self-citationThe Genes for Major Psychosis Aberrant Sequence or Regulation?
Petronis, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00127-5 · Cited by 84
Aberrant DNA Methylation on Chromosome 16 Is an Early Event in Hepatocarcinogenesis
Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., Sugimura, T., & Hirohashi, S. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03135.x · Cited by 83
Schmütte, C., Yang, A. S., Beart, R. W., & Jones, P. A. (1995) · PubMed · Cited by 83
Millar, D., Paul, C. L., Molloy, P. L., & Clark, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m906538199 · Cited by 82
Kokalj-Vokač, N., Almeida, A., Viégas-Pèquignot, E., Jeanpierre, M., Malfoy, B., & Dutrillaux, B. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133492 · Cited by 82
Bovenzi, V., Lê, N. L. O., Côté, S., Sinnett, D., Momparler, L. F., & Momparler, R. L. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199906000-00007 · Cited by 82
Hypomethylation in cervical tissue: is there a correlation with folate status?
Fowler, B. M., Giuliano, A. R., Piyathilake, C. J., Nour, M., & Hatch, K. D. (1998) · PubMed · Cited by 82
Mummaneni, P., Yates, P. A., Simpson, J. F., Rose, J., & Turker, M. S. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.22.5163 · Cited by 81
Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia
Nelkin, B. D., Przepiorka, D., Burke, P., Thomas, E., & Baylin, S. (1991) · Blood · doi:10.1182/blood.v77.11.2431.2431 · Cited by 81
Antequera, F., & Bird, A. P. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9118-9_8 · Cited by 81
Epigenetic Gene Inactivation Induced by a Cis-acting Methylation Center (*)
Mummaneni, P., Walker, K., Bishop, P. L., & Turker, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.788 · Cited by 74
Liang, G., Robertson, K. D., Talmadge, C. B., Sümegi, J., & Jones, P. A. (2000) · PubMed · Cited by 72
LINE-1: a human transposable element
Singer, M., Krek, V., McMillan, J., Swergold, G. D., & Thayer, R. E. (1993) · Gene · doi:10.1016/0378-1119(93)90064-a · Cited by 71
Zardo, G., & Caiafa, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16517 · Cited by 70
Pieper, R. O., Costello, J., Kroes, R. A., Futscher, B. W., Marathi, U. K., & Erickson, L. C. (1991) · Cancer Communications · doi:10.3727/095535491820873092 · Cited by 70
Self-citationArapshian, A., Kuppumbatti, Y. S., & Mira-y-Lopez, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203734 · Cited by 67
Psychiatric epigenetics: a new focus for the new century
Petronis, A., Gottesman, I. I., Crow, T. J., DeLisi, L. E., Klar, A. J. S., Macciardi, F. M., McInnis, M. G., McMahon, F. J., Paterson, A. D., Skuse, D., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000750 · Cited by 65
Formation and repair of DNA lesions in thep53 gene: Relation to cancer mutations?
Pfeifer, G. P., & Denissenko, M. F. (1998) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1998)31:3<197::aid-em1>3.0.co;2-i · Cited by 63
Akama, T. O., Okazaki, Y., Ito, M., Okuizumi, H., Konno, H., Muramatsu, M., Plass, C., Held, W. A., & Hayashizaki, Y. (1997) · PubMed · Cited by 62
Self-citationAberrant p27Kip1 promoter methylation in malignant melanoma
Worm, J., Bártková, J., Kirkin, A. F., Straten, P. T., Zeuthen, J., Bártek, J., & Guldberg, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203891 · Cited by 62
DNA Demethylase Is a Processive Enzyme
Cervoni, N., Bhattacharya, S. K., & Szyf, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8363 · Cited by 61
Hernandez, R., Frady, A., Zhang, X.-Y., Varela, M., & Ehrlich, M. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134548 · Cited by 61
Fr�hwald, M. C., O'Dorisio, M. S., Zunyan Dai, Y., Rush, L. J., Krahe, R., Smiraglia, D. J., Pietsch, T., Elsea, S. H., & Plass, C. (2000) · Genes Chromosomes and Cancer · Cited by 59
Self-citationLocalization of the ICF Syndrome to Chromosome 20 by Homozygosity Mapping
Wijmenga, C., van den Heuvel, L. P. W. J., Strengman, E., Luyten, J. A. F. M., van der Burgt, I. J. A. M., de Groot, R., Smeets, D., Draaisma, J. M. T., van Dongen, J. J. M., ABREU, R. A. D., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302021 · Cited by 58
Mammalian X Chromosome Inactivation
Gartler, S. M., Dyer, K. A., & Goldman, M. A. (1992) · Elsevier eBooks · doi:10.1016/b978-0-12-462002-5.50010-8 · Cited by 57
DNA methylation in genomic imprinting
Tycko, B. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(96)00049-x · Cited by 55
Qian, X. C., von Wronski, M. A., & Brent, T. P. (1995) · Carcinogenesis · doi:10.1093/carcin/16.6.1385 · Cited by 53
Rett syndrome and the MECP2 gene
Webb, T., & Latif, F. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.4.217 · Cited by 47
Tang, M. S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.1085 · Cited by 47
Most Jacobsen syndrome deletion breakpoints occur distal to FRA11B.
Michaelis, R. C., Velagaleti, G. V. N., Jones, C., Pivnick, E. K., Phelan, M. C., Boyd, E. R., Tarleton, J. C., Wilroy, R. S., Tunnacliffe, A., & Tharapel, A. T. (1998) · PubMed · Cited by 45
Analysis of the p16 tumor suppressor gene in early‐stage prostate cancer
Gu, K., Mes‐Masson, A., Gauthier, J. B., & Saad, F. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199803)21:3<164::aid-mc3>3.3.co;2-c · Cited by 45
Does Poly(ADP-ribosyl)ation Regulate the DNA Methylation Pattern?
Zardo, G., D’Erme, M., Reale, A., et al. (1997) · Biochemistry · doi:10.1021/bi970241s · Cited by 44
Yoshikawa, H., de la Monte, S. M., Nagai, H., Wands, J. R., Matsubara, K., & Fujiyama, A. (1996) · Genomics · doi:10.1006/geno.1996.0005 · Cited by 43
Altered methylation of versican proteoglycan gene in human colon carcinoma
Ádány, R., & Iozzo, R. V. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90841-a · Cited by 35
Mammalian X Chromosome Inactivation
Jaenisch, R., Beard, C., Lee, J. T., Marahrens, Y., & Panning, B. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515501.ch12 · Cited by 34
Familial eosinophilia: Clinical and laboratory results on a U.S. Kindred
Lin, A. Y., Nutman, T. B., Kaslow, D. C., Mulvihill, J. J., Fontaine, L. S., White, B. J., Knutsen, T., Theil, K. S., Raghuprasad, P. K., Goldstein, A. M., et al. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980319)76:3<222::aid-ajmg5>3.0.co;2-s · Cited by 34
Belinsky, S. A. (1998) · Experimental Lung Research · doi:10.3109/01902149809087381 · Cited by 32
Selective expression of intracisternal A-particle genes in established mouse plasmacytomas.
Lueders, K. K., Fewell, J. W., Morozov, V. E., & Kuff, E. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7439 · Cited by 32
Costello, J., Futscher, B. W., Kroes, R. A., & Pieper, R. O. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6515-6521.1994 · Cited by 30
Self-citationPolymorphisms, genomic imprinting and cancer susceptibility
Pulford, D. J., Falls, J. G., Killian, J. K., & Jirtle, R. L. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(98)00018-0 · Cited by 28
Zardo, G., Marenzi, S., Perilli, M., & Caiafa, P. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.12.1518 · Cited by 27
Kuzmin, I., Geil, L., Ge, H., Bengtsson, U., Duh, F.-M. C., Stanbridge, E. J., & Lerman, M. I. (1999) · Oncogene · doi:10.1038/sj.onc.1202959 · Cited by 20
Biallelic methylation and silencing of mouse Aprt in normal kidney cells.
Rose, J., Yates, P. A., Simpson, J. F., Tischfield, J. A., Stambrook, P. J., & Turker, M. S. (2000) · PubMed · Cited by 20
PCR-based approaches to adduct analysis
Pfeifer, G. P., Denissenko, M. F., & Tang, M. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00337-3 · Cited by 20
Chromatin modification and disease
Johnson, C. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.12.905 · Cited by 18
Pao, M. M., Liang, G., Tsai, Y., Xiong, Z., Laird, P. W., & Jones, P. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203414 · Cited by 17
Aberrant DNA Methylation of Genomic Regions Translocated in Myeloid Malignancies
Litz, C. E., & Etzell, J. E. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809050924 · Cited by 13
(1999) · doi:10.1002/(sici)1098-1004(1999)14:1
Cited by
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
Ehrich, M., Nelson, M. R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos, G., Cantor, C. R., Field, J. K., & van den Boom, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507816102 · Cited by 812
Epigenetic transgenerational actions of environmental factors in disease etiology
Skinner, M. K., Manikkam, M., & Guerrero-Bosagna, C. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.007 · Cited by 712
Metadata
- Authors
- Costello, J. F., & Plass, C.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2001-05-01
- Volume
- 38
- Issue
- 5
- Pages
- 285-303
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W4233749076
- Cited by
- 442
- References
- 306
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.